Foundation Medicine, Inc.
CAMBRIDGE, MA · Founded 2009 · CIK 0001488613 · Medtech · Acquired
Genomic sequencing tests for cancer diagnosis and treatment selection
foundationmedicine.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $59M
- 3 Form D · Sep 2012
- 169 months since last filing
- Contracts
- $158M
- 58 awards · Veterans Affairs, Defense, Health and Human S
- #8 of 4531 in medtech
- Patents
- 40
- 2 granted · 38 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2009201120132015201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $7,000,000 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $42,499,987 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Fee Basis Tests | $4,600 | |
| Federal contract | Department of Defense · Igf::ot::igf Lab Tests | $5,800 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf - Genomic Referral Testing Services | $5,600 | |
| Federal contract | Department of Veterans Affairs · One Foundation Optimized For Solid Tumor Testing On One Va Patient At The Durham Va Medical Center | $4,600 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Lab Testing For Solid Tumor (cancer) | $11,600 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf - Genomic Referral Testing Services | $5,600 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Provide Offsite Clinical Reference Laboratory Stat Testing Services To The Kansas City Vamc. | $4,600 | |
| Federal contract | Department of Veterans Affairs · Genomic Test | $5,800 | |
| Federal contract | Department of Defense · Igf::ot::igf Lab Tests, Foundation One | $5,800 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Foundationone Hematologic Testing | $3,500 | |
| Federal contract | Department of Defense · Igf::ot::igf Foundation One Lab Test | $5,800 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Urgent Testing | $4,200 | |
| Federal contract | Department of Veterans Affairs · Genetic Test | $5,800 | |
| Federal contract | Department of Defense · Solid Tumor Tc Patient A | $10,450 | |
| Federal contract | Department of Veterans Affairs · Tumor Mutational Burden (quantitative Genomic Marker) Services Visn 15 | $3,500 | |
| Federal contract | Department of Veterans Affairs · Solid Tumor And Hematologic Tumor Mutational Burden (quantitative Genomic Marker) Services; Wichita | $3,500 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf One Time Genetics Testing At The Vamc In Hines, Il. | $12,600 | |
| Federal contract | Department of Veterans Affairs · Tumor Mutational Burden (quantitative Genomic Marker) Services Visn 15 Task Order Award - Kc | $3,500 | |
| Federal contract | Department of Veterans Affairs · Tumor Mutational Burden (quantitative Genomic Marker) Services Visn 15 Task Order Award | $2,950 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Genomic Sequencing Testing Services Task Order | $6,686,063 | |
| Federal contract | Department of Veterans Affairs · Tumor Mutational Burden (quantitative Genomic Marker) Services Visn 15 Task Order Award | $2,950 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing Testing Services | $17,706,754 | |
| Federal contract | Department of Veterans Affairs · Hematologic Malignancies Testing | $2,606 | |
| Federal contract | Department of Veterans Affairs · Nop Hematologic Next Generation Sequencing Testing For The Richard L Roudebush Va Medical Center | $135,529 | |
| Federal contract | Department of Veterans Affairs · Hematologic Malignancies Ngs Test | $2,602 | |
| Federal contract· 1 of 2 same day | Department of Veterans Affairs · Genomic Sequencing Testing Services | $22,211,489 | |
| Federal contract· 2 of 2 same day | Department of Veterans Affairs · Hematologic Malignancies Ngs | $2,606 | |
| Federal contract | Department of Veterans Affairs · Reference Lab Test | $2,606 | |
| Federal contract | Department of Veterans Affairs · Hematologic Malignancies Testing Services | $2,606 | |
| Federal contract | Department of Veterans Affairs · Malignancies Testing, Ngs Wichita Vamc | $2,606 | |
| Federal contract | Department of Veterans Affairs · Test Malign | $2,606 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing Testing Services | $22,382,850 | |
| Federal contract | Department of Veterans Affairs · Reference Lab Test | $5,213 | |
| Federal contract | Department of Veterans Affairs · Heme Genomic Testing | $13,032 | |
| Federal contract | Department of Veterans Affairs · Next Generation Sequencing (ngs) Of Prostate Cancer Samples. | $5,000 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing Testing Services | $20,339,628 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing Testing Services | $22,374,867 | |
| Federal contract | Department of Veterans Affairs · Task Order For Base Year | $24,000,010 | |
| Federal contract | Department of Veterans Affairs · Hematologic Malignancy Next Generation Sequencing (nsg) Emergency | $110,000 | |
| Federal contract | Department of Veterans Affairs · Modification P1 To Add An Additional Poc For Fmi And Additional Report | $21,581,260 | |
| Federal contract | Department of Veterans Affairs · Igf:ct:igf:testing | $237,400 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 5 | CEPHEID | $219M | $5.2M |
| 6 | Spectral Md, Inc. | $189M | $1.1M |
| 7 | Synchron | $170M | $82M |
| 8 | Foundation Medicine, Inc. | $158M | $59M |
| 9 | Inbios International Inc | $146M | — |
| 10 | Crossject SA | $104M | $10M |
| 11 | Stratatech Corporation | $98M | $3.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Alexis BorisyDirector · Executive Officer
- ALEXIS BORISY, M.S.Director
- Brook ByersDirector
- Robert HessleinExecutive Officer
- Evan JonesDirector
- Kevin KrenitskyExecutive Officer
- KEVIN KRENITSKY, M.D.Executive Officer
- Mark LevinDirector
- MARK LEVINDirector
- Michael PelliniDirector · Executive Officer
- MICHAEL PELLINI, M.D.Director · Executive Officer
- Jason RyanExecutive Officer
- David SchenkeinDirector
- DAVID SCHENKEINDirector
- Robert TepperDirector
- ROBERT TEPPER, M.D.Director
- Krishna YeshwantDirector
Patents
- Systems And Methods For Identifying Mitochondrial Dna Variantsapplication
- Tree-based Model For Selecting Treatments And Determining Expected Treatment Outcomesapplication
- Therapeutic And Diagnostic Methods For Cancerapplication
- Methods For Evaluating Clonal Tumor Mutational Burdenapplication
- Methods And Systems For Detection Of Mismatch Repair Deficiencyapplication
- Braf Gene Fusions And Uses Thereofapplication
- Classification Of Samples Based On Methylation Analysis Of Dna Fragmentsapplication
- System And Method For Outcome Tracking And Analysisapplication
- Compositions And Methods For Evaluating Genomic Alterationsapplication
- Bcor Rearrangements And Uses Thereofgranted
- Oligonucleotides And Methods For Capturing Single-stranded Templates And/or Templates With 3' Overhangsapplication
- Novel Alk And NTRK1 Fusion Molecules And Uses Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.